Australian University Rankings Guide

The Neuroscientist: reviews at the interface of basic and clinical neurosciences (ERA Journal)

The Neuroscientist: reviews at the interface of basic and clinical neurosciences is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

The Neuroscientist: reviews at the interface of basic and clinical neurosciences issns are issn1: 1073-8584 issn2: 1089-4098.

The fields covered by The Neuroscientist: reviews at the interface of basic and clinical neurosciences as part of the evaluation of Australian university research excellence are:

Medical and Health Sciences Research Rankings (Major Field)

Psychology and Cognitive Sciences Research Rankings (Major Field)

Other ERA-accredited journals supporting the evaluation of the Medical and Health Sciences field include:

- Alter
- American Journal of Preventive Medicine
- Archives of the History and Philosophy of Medicine
- Biochemical Journal
- Biomedical and Environmental Sciences
- Current Biology
- JK Science: journal of medical education and research
- Journal of Computational Neuroscience
- Journal of Evidence-Based Medicine
- Journal of Physical Therapy Science
- Journal of Visual Impairment and Blindness
- Kathmandu University Medical Journal
- Molecular Psychiatry
- New Zealand Medical Journal
- Shimane Journal of Medical Science: an official journal of Shimane Medical University


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4